Caterina AM La Porta
Cited by
Cited by
Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential
E Monzani, F Facchetti, E Galmozzi, E Corsini, A Benetti, C Cavazzin, ...
European journal of cancer 43 (5), 935-946, 2007
Molecular mechanisms triggered by mercury
GP Guzzi, CAM La Porta
Toxicology 244 (1), 1-12, 2008
Glioblastoma‐derived tumorospheres identify a population of tumor stem‐like cells with angiogenic potential and enhanced multidrug resistance phenotype
A Salmaggi, A Boiardi, M Gelati, A Russo, C Calatozzolo, E Ciusani, ...
Glia 54 (8), 850-860, 2006
AQP1 is not only a water channel: it contributes to cell migration through Lin7/beta-catenin
E Monzani, R Bazzotti, C Perego, CAM La Porta
PloS one 4 (7), e6167, 2009
Modulation of pro-and anti-apoptotic factors in human melanoma cells exposed to histone deacetylase inhibitors
F Facchetti, S Previdi, M Ballarini, S Minucci, P Perego, CAM La Porta
Apoptosis 9 (5), 573-582, 2004
Cell–cell adhesion and 3D matrix confinement determine jamming transitions in breast cancer invasion
O Ilina, PG Gritsenko, S Syga, J Lippoldt, CAM La Porta, O Chepizhko, ...
Nature cell biology 22 (9), 1103-1115, 2020
Drug resistance in melanoma: new perspectives
CAM La Porta
Current medicinal chemistry 14 (4), 387-391, 2007
Increased plasma levels of soluble CD40, together with the decrease of TGFβ1, as possible differential markers of Alzheimer disease
A Mocali, S Cedrola, N Della Malva, M Bontempelli, VAM Mitidieri, ...
Experimental gerontology 39 (10), 1555-1561, 2004
CXCR6, a newly defined biomarker of tissue-specific stem cell asymmetric self-renewal, identifies more aggressive human melanoma cancer stem cells
R Taghizadeh, M Noh, YH Huh, E Ciusani, L Sigalotti, M Maio, B Arosio, ...
PloS one 5 (12), e15183, 2010
Topography of epithelial–mesenchymal plasticity
F Font-Clos, S Zapperi, CAM La Porta
Proceedings of the National Academy of Sciences 115 (23), 5902-5907, 2018
Unique expression and localization of aquaporin‐4 and aquaporin‐9 in murine and human neural stem cells and in their glial progeny
C Cavazzin, D Ferrari, F Facchetti, A Russignan, AL Vescovi, ...
Glia 53 (2), 167-181, 2006
Mechanism of drug sensitivity and resistance in melanoma.
CA La Porta
Current cancer drug targets 9 (3), 391-397, 2009
Cancer stem cells and therapeutic perspectives
E Galmozzi, F Facchetti, CAM Porta
Current medicinal chemistry 13 (6), 603-607, 2006
Cancer stem cells: lessons from melanoma
C La Porta
Stem Cell Reviews and Reports 5 (1), 61-65, 2009
Oral mucositis: the hidden side of cancer therapy
C Pulito, A Cristaudo, CL Porta, S Zapperi, G Blandino, A Morrone, ...
Journal of experimental & clinical cancer research 39 (1), 1-15, 2020
Senescent cells in growing tumors: population dynamics and cancer stem cells
CAM La Porta, S Zapperi, JP Sethna
PLoS computational biology 8 (1), e1002316, 2012
Decrease of TGF-β1 plasma levels and increase of nitric oxide synthase activity in leukocytes as potential biomarkers of Alzheimer's disease
B De Servi, CAM La Porta, M Bontempelli, R Comolli
Experimental gerontology 37 (6), 813-821, 2002
Do cancer cells undergo phenotypic switching? The case for imperfect cancer stem cell markers
S Zapperi, CAM La Porta
Scientific reports 2 (1), 1-7, 2012
Do cancer cells undergo phenotypic switching? The case for imperfect cancer stem cell markers
S Zapperi, CAM La Porta
Scientific reports 2 (1), 1-7, 2012
The water channels, new druggable targets to combat cancer cell survival, invasiveness and metastasis
E Monzani, AA Shtil, CAM La Porta
Current drug targets 8 (10), 1132-1137, 2007
The system can't perform the operation now. Try again later.
Articles 1–20